Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 61.97

-3.2%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2793)	2/5/2001 11:33:50 PM
From: Valueman	of 52153

CBST seems to be making a fuss in their presentations about dapto being bacteriocidal rather than bacteriostatic. I suppose this might offer the possibility of a quicker response, which could be significant in a life-threatening infection. I don't know enough to judge this issue, however. It's always a bonus to be -cidal v. -static as immunocompromised or severely debilitated patients may not have the white cell "power" to clean up the mess left by the bacteriostatic drugs. Those bugs are down, but not out, while the -static affected bugs are dead. Much less help is needed from one's own immune system. When I had a choice, I always went with bacteriocidal drugs, especially in the young.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next